ENTITY

BioStem Technologies (BSEM US)

10
Analysis
Health Care • United States
BioStem Technologies, Inc. is a regenerative medicine company. The Company focuses on the stem cell industry for treatment in a range of rare and common degenerative diseases.
more
bullish•BioStem Technologies
•19 Nov 2024 00:00•Issuer-paid

BSEM: Digging Into Medicare Issue

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
bullish•BioStem Technologies
•16 Nov 2024 06:00•Issuer-paid

BSEM: Digging Into Medicare Issue

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
bullish•BioStem Technologies
•18 Oct 2024 00:00•Issuer-paid

BSEM: Study Validates Technology and Important Medicare Decision Reached

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
bullish•BioStem Technologies
•03 Oct 2024 01:00•Issuer-paid

BSEM: Initiates Testing and Looks to Nasdaq

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
bullish•BioStem Technologies
•14 Aug 2024 00:00•Issuer-paid

BSEM: Growth Continue to Accelerate

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
x